Ear Sensor Enables Safe Telemedical Care for COVID-19 Risk Patients

Using telemedicine, COVID-19 patients can be cared for safely at home - from initial home isolation to recovery or, in case problems arise, admission to hospital. A team from the Technical University of Munich (TUM) has now successfully demonstrated this in a study involving 150 patients with risk factors for a severe progression of the disease.

COVID-19 patients are required to go into home isolation. But this can be dangerous for high-risk patients if they develop a severe progression during isolation. In this case, timely admission to the hospital for treatment can be critical for survival. Unfortunately, many COVID-19 patients do not immediately notice when their condition starts to deteriorate. The alternative of playing safe by admitting all at-risk patients immediately upon diagnosis would overburden the clinics.

Small effort - large gain in safety

During the recent Corona waves, Georg Schmidt and his team provided telemedical care to more than 150 patients with risk factors for a severe progression of the disease using an ear sensor that is easily worn behind the ear like a hearing aid.

The sensor recorded all important values such as body temperature, heart rate, respiration rate, and oxygen saturation in 15-minute intervals and transmitted the data to the telemedicine center at TUM’s university hospital Klinikum rechts der Isar. There, the team continuously monitored all incoming data. In addition, each participant was called at least once a day to inquire about his or her condition.

Whenever the team noticed a deterioration in the readings, they called the patient. A physician then took a decision on whether hospitalization was indicated. With minimal effort, the team achieved a quality of monitoring quite comparable to that at a hospital.

Great patient satisfaction

Around one in eight participants had to be admitted during the study. Interestingly, most of these patients later stated that they did not themselves realize the degree of deterioration in their condition.

"To our knowledge, this is the first study worldwide to continuously monitor patients in home isolation remotely and to prompt immediate hospitalization in the event of critical health deterioration," said Prof. Georg Schmidt, head of the Biosignal Processing Group at the Klinikum rechts der Isar.

The study illustrates that COVID-19 risk patients can be monitored effectively using telemedicine, potentially saving valuable resources in future waves of infection. Patients were also very satisfied and felt significantly safer thanks to the continuous monitoring.

Wurzer D, Spielhagen P, Siegmann A, Gercekcioglu A, Gorgass J, Henze S, Kolar Y, Koneberg F, Kukkonen S, McGowan H, Schmid-Eisinger S, Steger A, Dommasch M, Haase HU, Müller A, Martens E, Haller B, Huster KM, Schmidt G.
Remote monitoring of COVID-19 positive high-risk patients in domestic isolation: A feasibility study.
PLoS One. 2021 Sep 24;16(9):e0257095. doi: 10.1371/journal.pone.0257095

Most Popular Now

Artificial Intelligence in Healthcare Re…

This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of...

First-of-its-Kind Healthcare Communicati…

A web and mobile app-based start-up launched during the COVID-19 pandemic to help UK healthcare professionals communicate with patients has signed its first commercial agreement with a hospital trust...

Giving AI Penalties to Get Better Diagno…

Anyone waiting for the results of a medical test knows the anxious question: 'Will my life change completely when I know?' And the relief if you test negative. Nowadays, Artificial Intelligence...

New App Helps Parents Identify Treatable…

A ground-breaking new, mobile phone app, 'GrowthMonitor' places the accurate measurement of children's height in the hands of parents and carers. Preliminary data to be presented at the Society for...

DMEA Call for Papers: Digital Health in …

26 - 28 April 2022, Berlin, Germany. Health meets digitalisation. From 26 to 28 April 2022 DMEA - Connecting Digital Health, the leading platform for health IT, is opening its doors...

Health Meets IT: DMEA Newcomer Award Inv…

26 - 28 April 2022, Berlin, Germany. Digitalisation of our healthcare sector must be stepped up - the experience of recent months has shown that. It is why new ideas on...

Bittium Exhibits its High-Tech Medical T…

Bittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It...

Development of AI Technology for Produci…

Transcranial focused ultrasound can be used to treat degenerative movement disorders, intractable pain, and mental disorders by delivering ultrasound energy to a specific area of the brain without opening the...

Siemens Healthineers and UCSF Create Fir…

Siemens Healthineers and UC San Francisco have formed a research and innovation-driven collaboration to make radiological imaging greener, while improving access to and quality of radiological imaging in Northern California...

Tulane University Study Uses AI to Detec…

A Tulane University researcher found that artificial intelligence (AI) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study...

Dedalus Acquires Swiftqueue to Support P…

Dedalus Group ("Dedalus"), a leading international healthcare software solutions provider, has announced to have completed the acquisition of 100% of Swiftqueue Technologies Ltd a fast-growing cloud-native appointment and scheduling solution...

FDA Authorizes Marketing of Virtual Real…

The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with...